We are live on ! Find out more
RPTP

RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP

Delisted

RPTP was delisted on the 24th of October, 2016.

74 hedge funds and large institutions have $359M invested in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in 2014 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 28 increasing their positions, 20 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 20

27% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 11

17% more capital invested

Capital invested by funds: $308M → $359M (+$51.7M)

4% more funds holding

Funds holding: 7174 (+3)

9% less call options, than puts

Call options by funds: $19.1M | Put options by funds: $20.9M

Holders
74
Holders Change
+3
Holders Change %
+4.23%
% of All Funds
2.13%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
14
Increased
28
Reduced
20
Closed
11
Calls
$19.1M
Puts
$20.9M
Net Calls
-$1.84M
Net Calls Change
+$6.12M
Name Holding Trade Value Shares
Change
Change in
Stake
CS
1
Credit Suisse
Switzerland
$51.5M +$1.25M +137,618 +3%
Goldman Sachs
2
Goldman Sachs
New York
$44.8M +$9.78M +1,074,427 +38%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$35.6M -$2.28M -250,800 -8%
Royal Bank of Canada
4
Royal Bank of Canada
Ontario, Canada
$35M +$527K +57,900 +2%
BFA
5
BlackRock Fund Advisors
California
$26.4M -$1.31M -143,589 -6%
State Street
6
State Street
Massachusetts
$26M -$3.08M -338,107 -13%
BIT
7
BlackRock Institutional Trust
California
$24.8M -$793K -87,135 -4%
Vanguard Group
8
Vanguard Group
Pennsylvania
$22M +$437K +47,957 +3%
Group One Trading
9
Group One Trading
Illinois
$12.2M +$725K +79,585 +8%
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
$10.2M +$4.4M +483,229 +121%
Northern Trust
11
Northern Trust
Illinois
$8.38M -$789K -86,696 -11%
Nomura Holdings
12
Nomura Holdings
Japan
$5.25M -$2.06M -225,850 -32%
D.E. Shaw & Co
13
D.E. Shaw & Co
New York
$5M +$1.86M +204,422 +90%
Jane Street
14
Jane Street
New York
$4.45M +$3.38M +371,664 +2,807%
Lord, Abbett & Co
15
Lord, Abbett & Co
New Jersey
$4.44M +$3.5M +384,677 New
Geode Capital Management
16
Geode Capital Management
Massachusetts
$3.9M +$131K +14,337 +4%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$3.84M +$42.3K +4,650 +1%
Morgan Stanley
18
Morgan Stanley
New York
$3.48M +$1.33M +146,411 +95%
TCIM
19
TIAA CREF Investment Management
New York
$2.78M +$60.4K +6,638 +3%
ST
20
Spot Trading
Illinois
$2.32M +$1.83M +201,220 New
BIM
21
BlackRock Investment Management
Delaware
$2.09M +$141K +15,465 +9%
Charles Schwab
22
Charles Schwab
California
$2.07M +$89.2K +9,798 +6%
Allianz Asset Management
23
Allianz Asset Management
Germany
$1.47M +$258K +28,379 +29%
Deutsche Bank
24
Deutsche Bank
Germany
$1.41M +$602K +66,147 +119%
GC
25
Guggenheim Capital
Illinois
$1.32M -$1.25M -137,647 -55%

RPTP Hedge Fund Activity: Q2 2014 in Review

74 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) for Q2 2014, worth a combined $359M — up 17% from $308M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new RPTP positions and 11 closed out — a net gain of 3 holders — while 28 added to existing stakes and 20 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $9.78M. The largest seller was Assured Investment Management, exiting entirely with an estimated $9.89M sold.

  • 74 institutional investors held RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) as of Q2 2014, up from 71 in Q1 2014.
  • Funds reported $359M of RAPTOR PHARMACEUTICAL CORP COM STK (DE) stock for Q2 2014, up 17% quarter-over-quarter.
  • 14 funds opened new RAPTOR PHARMACEUTICAL CORP COM STK (DE) positions in Q2 2014 and 11 closed out, a net change of +3 holders.
  • The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) buyer in Q2 2014 was Goldman Sachs, an estimated $9.78M added.
  • The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) seller in Q2 2014 was Assured Investment Management, an estimated $9.89M sold.

Based on aggregated 13F filings for Q2 2014.